Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.425 USD | +7.14% |
|
+7.46% | -21.74% |
May. 21 | Biodesix, Inc. to Present New Data on the Nodify XL2 Test at ATS 2024 Annual Meeting | CI |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.74% | 193M | |
-22.13% | 7.9B | |
+74.03% | 4.53B | |
+8.00% | 2.78B | |
-2.80% | 2.64B | |
-50.41% | 1.99B | |
-19.00% | 1.66B | |
-20.57% | 1.49B | |
+19.61% | 1.23B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix Shares Rise After Cowen Starts Coverage With Outperform Rating